Ryan Moore, MD, discusses the choice between surgery and total neoadjuvant therapy (TNT) for rectal cancer and when watch-and-wait is feasible post-TNT.
Ryan Moore, MD
Advertisement
Articles by Ryan Moore, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Selpercatinib Shows Durable Responses in Pediatric Solid Tumors
2
2026 AACR Report Highlights Advances and New Directions in Cancer Treatment
3
ESMO 2026 Preview: Late-Breaking Studies to Watch Across Tumor Types
4
Dostarlimab Receives FDA Approval for MSI-H/dMMR Locally Advanced Rectal Cancer
5